UBS faces renewed investor unease after agreeing to pay $300 million to the U.S. Department of Justice to settle legacy claims tied to Credit Suisse’s 2017 mortgage-backed securities case. The Swiss banking giant’s shares dropped 2.56% to 29.66 francs on the SIX exchange following the announcement, reflecting market jitters over lingering liabilities from its emergency takeover of Credit Suisse in March 2023. The payment resolves consumer compensation obligations linked to toxic residential mortgages (RMBS), a recurring issue for Credit Suisse, which had previously paid $495 million in a similar 2022 settlement.
Accounting Silver Lining Amid Ongoing Cleanup
Despite the financial hit, UBS expects a partial offset in Q3 2025 through the release of provisions booked during the acquisition. The bank emphasized its commitment to resolving inherited liabilities "promptly and responsibly," but investors remain wary of undisclosed risks. This latest settlement underscores the protracted challenges of integrating Credit Suisse’s troubled legacy, with UBS systematically addressing legal and financial fallout to stabilize its market position.
Ad
UBS Stock: Buy or Sell?! New UBS Analysis from November 7 delivers the answer:
The latest UBS figures speak for themselves: Urgent action needed for UBS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 7.
UBS: Buy or sell? Read more here...
